| Financial Year |
March 31 2023 |
| Monetary Funds |
775,574,364.16 |
| Held-for-trading Financial Assets |
445,303,748.10 |
| Notes Receivable |
50,000.00 |
| Accounts Receivable |
120,668,502.58 |
| Advances to Suppliers |
3,798,918.68 |
| Other Receivables |
663,512.03 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
60,987,666.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,622,476.66 |
| Total Current Assets |
1,408,669,188.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
206,146,269.85 |
| Under-construction Projects |
11,202,249.31 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
28,401,237.02 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
1,833,763.63 |
| Sub-Total of Non-Current Assets |
650,700,678.87 |
| Total Assets |
2,059,369,867.12 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
70,158,084.07 |
| Accounts Payable |
81,315,595.41 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,468,432.38 |
| Taxes Payable |
8,090,034.52 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,739,553.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,930,207.66 |
| Other Current Liabilities |
56,951.24 |
| Sub-Total of Current Liabilities |
182,902,979.96 |
| Long-term Loans |
5,799,652.90 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
17,394,921.76 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
55,723,161.02 |
| Total Liabilities |
238,626,140.98 |
| Paid-In Capital(Or Share Stock) |
81,209,818.00 |
| Capital Surplus |
1,022,330,045.77 |
| Surplus Reserve |
66,730,706.19 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
649,520,860.81 |
| Minority Stockholder's Interest |
952,295.37 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,819,791,430.77 |
| Owner's Equity（Stockholder's Equity） |
1,820,743,726.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,059,369,867.12 |
